Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)
·MeSH: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 4(1)
Frequently asked questions
How many drugs are in development for Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)?
BioSniper tracks 1 drug in development for Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD) across 1 company.
How many clinical trials target Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)?
There are 1 clinical trial targeting Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD) tracked by BioSniper.
Deep-dive into Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis